SITC Archive Library

2015 Advances in Cancer Immunotherapy™ - San Francisco, CA 

02-03-2017 15:19

2015 Advances in Cancer Immunotherapy™ - San Francisco, CA
November 18, 2015
San Francisco Marriott Marquis San Francisco, CA

Program Organizers
Adil Daud, MD – University of California San Francisco
Lawrence Fong, MD – University of California San Francisco
Antoni Ribas, MD, PhD – University of California Los Angeles

Program Summary
From the Society for Immunotherapy of Cancer (SITC), these enduring materials from the 2015 Advances in Cancer Immunotherapy™ - San Francisco, CA provides an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumor immunology and cancer immunotherapy, this program facilitated an understanding of:

  1. The underlying principles of tumor immunology and immunotherapy
  2. The clinical indications for cancer immunotherapy and appropriate selection of patients
  3. Patient management
  4. The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes. 
Intended Audience
The target audience for this program included clinical oncologists, registered nurses, nurse practitioners, others involved in patient care, early career individuals, allied health professionals and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients. 

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#AdvancesinCancerImmunotherapy(ACI) #SITC #PresentationSlides #RegisteredNurse #Oncologist #AdoptiveCellTherapy #2015 #ImmuneCheckpointInhibitors #Clinician #Toxicities #Ipilimumab
#Nivolumab#CombinationTherapy #AdoptiveCellTherapy #Cytokines​​ #Biomarkers #ClinicalTrials
#Leukemia #Lymphoma #Melanoma #Myeloma #Non-SmallCellLungCancer #BrainCancers
#ProstateCancer #AdverseEvents #Pembrolizumab #Vaccines #AlliedHealth #Pharmacist #PrimaryCarePhysician

Statistics
0 Favorited
44 Views
6 Files
0 Shares
472 Downloads
Attachment(s)
pdf file
Immunology 101 for the Practicing Oncologist Presentation...   1.88 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Principles of Tumor Immunology; Presentation: Immunology 101 for the Practicing Oncologist; Presenters: Aaron Logan, MD, PhD – University of California San Francisco; Date: November 18, 2015
pdf file
Applying Basic Immunology to Treat Cancer Presentation Sl...   3.71 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Principles of Tumor Immunology; Presentation: Applying Basic Immunology to Treat Cancer; Presenters: Lawrence Fong, MD – University of California San Francisco; Date: November 18, 2015
pdf file
The Immune Suppressive Tumor Microenvironment Presentatio...   2.40 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Principles of Tumor Immunology; Presentation: The Immune Suppressive Tumor Microenvironment; Presenters: Thomas F. Gajewski, MD, PhD – University of Chicago; Date: November 18, 2015
pdf file
Checkpoint Inhibitor Therapy Presentation Slides   4.17 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Checkpoint Inhibitor Therapy; Presenters: Antoni Ribas, MD, PhD – University of California Los Angeles; Date: November 18, 2015
pdf file
Treatments to Perturb the Tumor Microenvironment Presenta...   2.61 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Treatments to Perturb the Tumor Microenvironment; Presenters: Siwen Hu-Lieskovan, MD, PhD – University of California Los Angeles; Date: November 18, 2015
pdf file
Current Status of Chimeric and Adoptive T Cell Therapy Pr...   3.37 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- San Francisco, CA; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Current Status of Chimeric and Adoptive T Cell Therapy; Presenters: Stephen J. Forman, MD – City of Hope National Medical Center; Date: November 18, 2015